SCHEMBL4567264

SCHEMBL4567264

CC(=O)C(=O)OCCCCOC(=O)C(C)=O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
ALDH1A1 P00352 2/20 0.46
NAAA Q02083 1/20 0.41
RAD52 P43351 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP3A4 P08684 1/20 0.39
EPHX1 P07099 1/20 0.38
THRB P10828 1/20 0.38
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
ATM Q13315 1/20 0.37
ACHE P22303 6/20 0.37
GLO1 Q04760 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1083216 0.90 TSHR (0.67) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL22607980 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL6562247 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL3018392 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL521587 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL22647718 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL919347 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL22647791 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL22647724 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1
SCHEMBL9345377 0.88 TSHR (0.70) TSHRALDH1A1NAAARAD52NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221741-B2 Ketocarboxylic acids, ketocarboxylic esters, methods of manufacture and uses thereof SEGETIS, INC. (US) 2015-12-29 US disclosed
US-9221741-B2 Ketocarboxylic acids, ketocarboxylic esters, methods of manufacture and uses thereof SEGETIS, INC. (US) 2015-12-29 US disclosed
US-20130296601-A1 KETOCARBOXYLIC ACIDS, KETOCARBOXYLIC ESTERS, METHODS OF MANUFACTURE AND USES THEREOF GFBIOCHEMICALS LIMITED (MT) 2013-11-07 US disclosed
US-20130296601-A1 KETOCARBOXYLIC ACIDS, KETOCARBOXYLIC ESTERS, METHODS OF MANUFACTURE AND USES THEREOF GFBIOCHEMICALS LIMITED (MT) 2013-11-07 US disclosed
US-8507718-B2 Ketocarboxylic acids, methods of manufacture and uses thereof SEGETIS, INC. (US) 2013-08-13 US disclosed
US-8507718-B2 Ketocarboxylic acids, methods of manufacture and uses thereof SEGETIS, INC. (US) 2013-08-13 US disclosed
US-20120123147-A1 KETOCARBOXYLIC ACIDS, METHODS OF MANUFACTURE AND USES THEREOF SEGETIS, INC. (US) 2012-05-17 US disclosed
US-20120123147-A1 KETOCARBOXYLIC ACIDS, METHODS OF MANUFACTURE AND USES THEREOF SEGETIS, INC. (US) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123147-A1 KETOCARBOXYLIC ACIDS, METHODS OF MANUFACTURE AND USES THEREOF PHYKPL, HACL2, MCCC2 TSHR 4165/4885ALDH1A1 1223/4885NAAA 476/4885
US-20130296601-A1 KETOCARBOXYLIC ACIDS, KETOCARBOXYLIC ESTERS, METHODS OF MANUFACTURE AND USES THEREOF PHYKPL, HACL2, MCCC2 TSHR 3953/4885ALDH1A1 1119/4885NAAA 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.